{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-12446", "FDA", "Requests that the FDA declare that Diclofenac Sodium Topical Solution, 1.6%, is suitable for submission as an ANDA", "Nonrulemaking", "2026-10-14T20:14:10Z", "0b000064b966d8c8", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-12446"], "units": {}, "query_ms": 0.28076604939997196, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}